Poor glycemic control is associated with the risk of subclinical hypothyroidism in patients with type 2 diabetes mellitus
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Overt hypothyroidism is frequently found in patients with type 2 diabetes mellitus (T2DM), but it remains unknown the relationship between subclinical hypothyroidism (SCH) and T2DM. We attempt to evaluate the difference in prevalence of SCH between patients with T2DM and general population, and the association between SCH and glycemic control status ofdiabetic patients. Methods: This was cross-sectional study. Total 8,528 subjects who visited for health check-up were recruited. SCH was defined as an elevated level of serum thyroid stimulating hormone (> 4.0 mIU/L) with a normal level of free thyroxine. T2DM group was categorized into three groups by glycosylated hemoglobin (HbA1c): < 7% (reference), ≥ 7% and < 9%, ≥ 9%. Results: Finally, 7,966 subjects were included. The prevalence of SCH was not different between healthy controls and subjects with T2DM (8.1% vs. 7.4%, p = 0.533; in men, 5.7% vs. 5.1%, p = 0.573; in women, 10.9% vs. 11.7%, p = 0.712), but it was increased with highest HbA1c group more than well controlled group, especially in women. The risk of SCH was increased by group with poorer glycemic control; the odds ratio for HbA1c ≥ 9% compared to < 7% was 2.52 (95% confidence interval [CI], 1.09 to 5.86; p = 0.031), and 4.58 (95% CI, 1.41 to 14.87; p = 0.011) in women, but not significant in men. Conclusions: The prevalence of SCH was similar between T2DM and healthy group. Poor glycemic control in T2DM was obviously associated with the risk of SCH, especially in elderly women. These results suggest SCH as comorbidity may be considered in elderly women with poor glycemic control.
Abstract
Background/Aims: Overt hypothyroidism is frequently found in patients with type 2 diabetes mellitus (T2DM), but it remains unknown the relationship between subclinical hypothyroidism (SCH) and T2DM. We attempt to evaluate the difference in prevalence of SCH between patients with T2DM and general population, and the association between SCH and glycemic control status ofdiabetic patients. Methods: This was cross-sectional study. Total 8,528 subjects who visited for health check-up were recruited. SCH was defined as an elevated level of serum thyroid stimulating hormone (> 4.0 mIU/L) with a normal level of free thyroxine. T2DM group was categorized into three groups by glycosylated hemoglobin (HbA1c): < 7% (reference), ≥ 7% and < 9%, ≥ 9%. Results: Finally, 7,966 subjects were included. The prevalence of SCH was not different between healthy controls and subjects with T2DM (8.1% vs. 7.4%, p = 0.533; in men, 5.7% vs. 5.1%, p = 0.573; in women, 10.9% vs. 11.7%, p = 0.712), but it was increased with highest HbA1c group more than well controlled group, especially in women. The risk of SCH was increased by group with poorer glycemic control; the odds ratio for HbA1c ≥ 9% compared to < 7% was 2.52 (95% confidence interval [CI], 1.09 to 5.86; p = 0.031), and 4.58 (95% CI, 1.41 to 14.87; p = 0.011) in women, but not significant in men. Conclusions: The prevalence of SCH was similar between T2DM and healthy group. Poor glycemic control in T2DM was obviously associated with the risk of SCH, especially in elderly women. These results suggest SCH as comorbidity may be considered in elderly women with poor glycemic control.
참고문헌 (31)
- Helfand M, "Clinical guideline, part 2. Screening for thyroid disease: an update. American College of Physicians", Ann Intern Med, 129, pp.144~158 (1998)
- Bindels AJ, "The prevalence of subclinical hypothyroidism at different total plasma cholesterol levels in middle aged men and women: a need for case-finding?", Clin Endocrinol, 50, pp.217~220 (1999)
- Tsimihodimos V, "The incidence of thyroid function abnormalities in patients attending an outpatient lipid clinic", Thyroid, 9, pp.365~368 (1999)
- Pirich C, "Prevalence and relevance of thyroid dysfunction in 1922 cholesterol screening participants", J Clin Epidemiol, 53, pp.623~629 (2000)
- Tzotzas T, "Changes in lipoprotein(a)levels in overt and subclinical hypothyroidism before and during treatment", Thyroid, 10, pp.803~808 (2000)
- Hak AE, "Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study", Ann Intern Med, 132, pp.270~278 (2000)
- Canaris GJ, "The Colorado thyroid disease prevalence study", Arch Intern Med, 160, pp.526~534 (2000)
- Badman MK, "Should thyroid function tests be done annually in all patients with diabetes?", Diabet Med, 19(Suppl 3), pp.7~9 (2002)
- McDermott MT, "Subclinical hypothyroidism is mild thyroid failure and should be treated", J Clin Endocrinol Metab, 86, pp.4585~4590 (2001)
- Cooper DS, "Clinical practice: subclinical hypothyroidism", N Engl J Med, 345, pp.260~265 (2001)
- Hollowell JG, "Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)", J Clin Endocrinol Metab, 87, pp.489~499 (2002)
- Feely J, "Screening for thyroid dysfunction in diabetics", Br Med J, 1, pp.1678~ (1979)
- Gray RS, "Screening for thyroid dysfunction in diabetics", Br Med J, 2, pp.1439~ (1979)
- Perros P, "Frequency of thyroid dysfunction in diabetic patients: value of annual screening", Diabet Med, 12, pp.622~627 (1995)
- Smithson MJ, "Screening for thyroid dysfunction in a community population of diabetic patients", Diabet Med, 15, pp.148~150 (1989)
- Ishay A, "Prevalence of subclinical hypothyroidism in women with type 2 diabetes", Med Sci Monit, 15, pp.CR151~CR155 (2009)
- American Diabetes Association, "Standards of medical care in diabetes: 2014", Diabetes Care, 37(Suppl 1), pp.S14~S80 (2014)
- Palma CC, "Prevalence of thyroid dysfunction in patients with diabetes mellitus", Diabetol Metab Syndr, 5, pp.58~ (2013)
- Papazafiropoulou A, "Prevalence of thyroid dysfunction among Greek type 2 diabetic patients attending an outpatient clinic", J Clin Med Res, 2, pp.75~78 (2010)
- Celani MF, "Prevalence of abnormal thyrotropin concentrations measured by a sensitive assay in patients with type 2 diabetes mellitus", Diabetes Res, 27, pp.15~25 (1994)
- Hage M, "Thyroid disorders and diabetes mellitus", J Thyroid Res, 2011, pp.439463~ (2011)
- Gronich N, "Hypothyroidism is a risk factor for new-onset diabetes: a cohort study", Diabetes Care, 38, pp.1657~1664 (2015)
- Sawin CT, "The aging thyroid: thyroid deficiency in the Framingham Study", Arch Intern Med, 145, pp.1386~1388 (1985)
- Tuzcu A, "Subclinical hypothyroidism may be associated with elevated high-sensitive c-reactive protein (low grade inflammation)and fasting hyperinsulinemia", Endocr J, 52, pp.89~94 (2005)
- Maratou E, "Studies of insulin resistance in patients with clinical and subclinical hypothyroidism", Eur J Endocrinol, 160, pp.785~790 (2009)
- Kim BY, "Association between subclinical hypothyroidism and severe diabetic retinopathy in Korean patients with type 2diabetes", Endocr J, 58, pp.1065~1070 (2011)
- Mervat M. El-Eshmawy, "Subclinical Hypothyroidism Is Independently Associated with Microalbuminuria in a Cohort of Prediabetic Egyptian Adults (Diabetes Metab J 2013;37:450-7)", Diabetes and Metabolism Journal, 38(1), pp.85~86 (2014), 대한당뇨병학회[DOI]
- Ashwini S, "Mild hypothyroidism improves glucose tolerance in experimental type 2 diabetes", Chem Biol Interact, 235, pp.47~55 (2015)
- Staub JJ, "Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues", Am J Med, 92, pp.631~642 (1992)
- Gray RS, "Hypercholesterolemia in diabetics with clinically unrecognised primary thyroid failure", Horm Metab Res, 13, pp.508~510 (1981)
- Hueston WJ, "Subclinical hypothyroidism and the risk of hypercholesterolemia", Ann Fam Med, 2, pp.351~355 (2004)